HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Calif. Chemical Reg Advances Without Industry-Requested Changes

This article was originally published in The Rose Sheet

Executive Summary

California’s regulation, which will create a list of chemicals of concern and target product categories containing priority chemicals for alternatives assessments, moves into the final stage of review without industry-proposed revisions to reduce costs and burdens associated with compliance. The state’s Department of Toxic Substances Control says it has not yet determined what ingredients and products will make those lists.

You may also be interested in...

Problems Remain In Calif. Consumer Products Reg, Slated For October

The Personal Care Products Council faults the latest and likely last draft of California’s Safer Consumer Products regs for its lack of a weight-of-evidence approach to decision making and inadequate trade-secret protections, among other shortcomings.

Perrigo’s Pending OTC Launches Promising But Pandemic Precludes Pumping Guidance

A diclofenac topical analgesic is first, likely followed by a line extension for its Prevacid 24HR PPI brand. Perrigo also plans to introduce natural-based products that “leverage our expertise in Europe."

Like Consumer Health Ad Claims About COVID-19, Customer Testimonials Are False And Misleading

Nomolotus discontinued social media claims that its herbal supplement supports users’ immune systems during the COVID-19 pandemic and customers reviews referencing the virus after the National Advertising Division questioned the statements as misleading. 




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts